𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis

✍ Scribed by Thierry Soussi; Karim Dehouche; Christophe Béroud

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
331 KB
Volume
15
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

The p53 tumor suppressor gene has proven to be one of the genes most often mutated in human cancers. It involves mainly point mutations leading to amino acid substitutions in the central region of the protein which impairs normal functions. Analysis of the mutational events that target the p53 gene has revealed evidence for both exogenous and endogenous mutational mechanisms. For example, the p53 mutational spectrum reveals evidence for a direct causal effect of ultraviolet radiation in skin cancer, of aflatoxin B1 in liver cancer, and of tobacco smoke in lung cancer. This novel field, molecular epidemiology of human cancer risk, has added a new dimension to classical associative epidemiology by providing a direct link between human cancer and carcinogen exposure. For such analysis, we devised a generic software called UMD (Universal Mutation Database). It was developed as a generic software to create locus-specific databases (LSDBs) with the 4 th Dimension® package from ACI. This software includes an optimized structure to assist and secure data entry and to allow the input of various clinical data.

📜 SIMILAR VOLUMES

Clonality and stability of the p53 gene
Clonality and stability of the p53 gene in human astrocytic tumor cells: Quantitative analysis of p53 gene mutations by yeast functional assay
✍ Mitsuhiro Tada; Richard D. Iggo; Nobuaki Ishii; Yumiko Shinohe; Shirou Sakuma; A 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 437 KB 👁 2 views

Mutation of the p53 gene is found in about one third of astrocytic brain tumors, and expansion of tumor cell clones containing mutant p53 has been implicated in astrocytic tumor progression. However, admixture of normal cells in astrocytic tumor specimens limits the power of traditional studies of t

Abnormal p53 expression is rare in clini
Abnormal p53 expression is rare in clinically localized human prostate cancer: Comparison between immunohistochemical and molecular detection of p53 mutations
✍ Mottaz, Alain E.; Markwalder, Regula; Fey, Martin F.; Klima, Irena; Merz, Vincen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views

## BACKGROUND. We assessed the frequency and molecular basis of p53 mutations in clinically localized prostatic adenocarcinoma. METHODS. Prostate specimens were examined from 100 patients with clinically localized prostatic adenocarcinoma and 13 patients with benign prostatic hyperplasia (BPH). Mu

Comparison between p53 protein measureme
Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors
✍ Torbjörn Norberg; Johan Lennerstrand; Mats Inganäs; Jonas Bergh 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 120 KB 👁 2 views

The p53 mutational status of 226 representative primary breast cancer samples, derived from a population-based cohort, was analyzed using cDNA-based sequencing. The results were compared with those obtained with immunohistochemistry (IHC) on microwave-treated paraffin sections and the p53 specific l

Evidence that mutational activation of t
Evidence that mutational activation of the ras genes may not be involved in aflatoxin B1–induced human hepatocarcinogenesis, based on sequence analysis of the ras and p53 genes
✍ Hung-Kun Chao; Ting-Fen Tsai; Chang-Shen Lin; Tsung-Sheng Su 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Exposure to aflatoxin B 1 (AFB 1 ) is one of the risk factors for developing hepatoma. In rats, activation of the ras gene is a prevalent event in AFB 1 -induced hepatocarcinogenesis. It is not clear whether a similar event occurs in humans. By analysis of codon 249 of the p53 gene, six of 36 human